Stonebridge Capital Advisors’s NEOPHOTONICS CORP NPTN Stock Holding History

Stonebridge Capital Advisors’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-500	Closed	-$8K	–	1153
2022 Q2	$8K	Sell	500 -500	-50%	-$7.63K	﹤0.01%	651
2022 Q1	$15K	Hold	1,000	–	–	﹤0.01%	596
2021 Q4	$15K	Hold	1,000	–	–	﹤0.01%	576
2021 Q3	$9K	Sell	1,000 -1,000	-50%	-$9.12K	﹤0.01%	640
2021 Q2	$22K	Buy	2,000 +1,000	+100%	+$10.6K	﹤0.01%	608
2021 Q1	$12K	Buy	+1,000	New	+$11.3K	﹤0.01%	605
2020 Q3	–	Sell	-500	Closed	-$4K	–	770
2020 Q2	$4K	Hold	500	–	–	﹤0.01%	606
2020 Q1	$4K	Hold	500	–	–	﹤0.01%	591
2019 Q4	$4K	Hold	500	–	–	﹤0.01%	689
2019 Q3	$3K	Hold	500	–	–	﹤0.01%	693
2019 Q2	$2K	Buy	+500	New	+$2.64K	﹤0.01%	805

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Stonebridge Capital Advisors's NPTN Position: Q3 2022 in Review

Stonebridge Capital Advisors sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 500 shares — an estimated $8K sold.

Stonebridge Capital Advisors first reported a position in NPTN in Q2 2019 and held it in 11 quarters. The position peaked at $22K in Q2 2021. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

Stonebridge Capital Advisors reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
Stonebridge Capital Advisors sold 500 NEOPHOTONICS CORP shares in Q3 2022, an estimated $8K.
Stonebridge Capital Advisors first reported a position in NEOPHOTONICS CORP in Q2 2019 and held it in 11 quarters.
Stonebridge Capital Advisors's NEOPHOTONICS CORP position peaked at $22K in Q2 2021.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Stonebridge Capital Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.